Related Experiment Video
Updated: May 24, 2026

An Electrochemiluminescence-Based Assay for MeCP2 Protein Variants
Published on: May 22, 2020
Reduced expression of MECP2 affects cell commitment and maintenance in neurons by triggering senescence: new
Tiziana Squillaro1, Nicola Alessio, Marilena Cipollaro
1Department of Experimental Medicine, Biotechnology and Molecular Biology Section, Second University of Naples, 80138 Naples, Italy.
Abstract:
MECP2 protein binds preferentially to methylated CpGs and regulates gene expression by causing changes in chromatin structure. The mechanism by which impaired MECP2 activity can induce pathological abnormalities in the nervous system of patients with Rett syndrome (RTT) is not clearly understood. To gain further insight into the role of MECP2 in human neurogenesis, we compared the neural differentiation process in mesenchymal stem cells (MSCs) obtained from a RTT patient and from healthy donors. We further analyzed neural differentiation in a human neuroblastoma cell line carrying a partially silenced MECP2 gene. Senescence and reduced expression of neural markers were observed in proliferating and differentiating MSCs from the RTT patient, which suggests that impaired activity of MECP2 protein may impair neural differentiation, as observed in RTT patients. Next, we used an inducible expression system to silence MECP2 in neuroblastoma cells before and after the induction of neural differentiation via retinoic acid treatment. This approach was used to test whether MECP2 inactivation affected the cell fate of neural progenitors and/or neuronal differentiation and maintenance. Overall, our data suggest that neural cell fate and neuronal maintenance may be perturbed by senescence triggered by impaired MECP2 activity either before or after neural differentiation.
Insights
Impaired MECP2 protein activity causes senescence and hinders neural differentiation in Rett syndrome (RTT) patients. This suggests MECP2 is crucial for maintaining neural cell fate and neuronal health.
Area of Science:
- Neuroscience
- Genetics
- Cell Biology
Background:
- Methyl-CpG-binding protein 2 (MECP2) regulates gene expression and chromatin structure.
- The precise mechanism linking MECP2 dysfunction to neurological abnormalities in Rett syndrome (RTT) remains unclear.
- Understanding MECP2's role in human neurogenesis is vital for RTT research.
Purpose of the Study:
- To investigate the impact of MECP2 dysfunction on human neurogenesis.
- To compare neural differentiation in mesenchymal stem cells (MSCs) from RTT patients and healthy donors.
- To analyze neural differentiation in a neuroblastoma cell line with silenced MECP2.
Main Methods:
- Comparison of neural differentiation in RTT patient-derived MSCs versus healthy donor MSCs.
- Analysis of neural differentiation in a human neuroblastoma cell line with partially silenced MECP2.
- Utilizing an inducible expression system to silence MECP2 in neuroblastoma cells before and after retinoic acid-induced neural differentiation.
Main Results:
- Mesenchymal stem cells from RTT patients exhibited senescence and reduced neural marker expression during differentiation.
- MECP2 silencing in neuroblastoma cells, both before and after neural induction, led to perturbed neural cell fate and maintenance.
- Data indicate that MECP2 deficiency triggers senescence, impacting neural differentiation and neuronal stability.
Conclusions:
- Impaired MECP2 activity compromises neural differentiation and contributes to RTT pathology.
- Senescence induced by MECP2 dysfunction plays a significant role in neural development defects observed in RTT.
- MECP2 is essential for maintaining neural cell fate and neuronal integrity throughout neurogenesis.
Related Concept Videos
Master Transcription Regulators
Replicative Cell Senescence
Abnormal Proliferation
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Negative Regulator Molecules

